MedPath

Evaluation the effect of chicory in iron deposition in liver and heart in major thalassemia patients.

Phase 3
Recruiting
Conditions
Beta thalassemia major.
Beta thalassemia
D56.1
Registration Number
IRCT20240121060755N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
52
Inclusion Criteria

Consent of patients to participate in the study
Suffering from thalassemia major treated with periodic pac cell transfusion
Ferritin level above 500

Exclusion Criteria

Reluctance to continue studying
Occurrence of skin complications or other symptoms suggestive of sensitivity to chicory plant extract
Viral hepatitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Iron deposition in the liver. Timepoint: Measurement of Iron deposition in the liver at the beginning of the study (before the start of the intervention), 3 months after consuming chicory. Method of measurement: MRI.
Secondary Outcome Measures
NameTimeMethod
Iron deposition in the heart. Timepoint: Measurement of iron deposition in the liver at the beginning of the study (before the start of the intervention), 3 months after consuming chicory. Method of measurement: MRI.
© Copyright 2025. All Rights Reserved by MedPath